{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:43:05Z","timestamp":1770748985927,"version":"3.50.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health\u223cHolland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Top Sector Life Sciences & Health","doi-asserted-by":"crossref","award":["LSHM17074"],"award-info":[{"award-number":["LSHM17074"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare inflammatory and structural differences in active PsA between DMARD-naive and DMARD-failure patients using diverse imaging approaches for future analyses. Additionally, to explore the influence of patient characteristics (clinical and demographic variables) on imaging findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Of the 80 patients included from the first cohort of the ongoing multicentre TOFA-PREDICT trial, 40 were DMARD-naive and 40 were DMARD-failure (csDMARD failure; one prior bDMARD excluding etanercept was allowed), all meeting classification criteria for PsA with a minimum disease duration of eight weeks. Baseline conventional radiographs of hands and feet, MRIs of both ankles, and whole-body [18F]-fluorodeoxyglucose PET\/CT\u00a0(18F-FDG PET\/CT) were evaluated for inflammatory and structural imaging parameters, including Sharp-van der Heijde (SHS), Heel Enthesitis Magnetic Resonance Imaging Scoring System (HEMRIS) and Deauville synovitis scoring. Differences between groups and the influence of patient characteristics were examined with multiple linear regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At baseline, patient characteristics were similar between groups. Imaging parameters showed limited inflammation and structural damage. Inflammatory imaging parameters were not significantly different (P\u2009&amp;gt;\u20090.200). Among structural parameters, only HEMRIS Achilles tendon structural damage was significantly different (P\u2009=\u20090.024, R2\u2009=\u20090.071) and SHS Joint Space Narrowing was not statistically significant (P\u2009=\u20090.050, R2\u2009=\u20090.048) with higher values for both in DMARD failures. After correction of patient characteristics, these differences in imaging disappeared (both P\u2009&amp;gt;\u20090.600).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>At baseline, PsA patient groups were comparable concerning structural and inflammatory imaging parameters, especially after correcting for patient characteristics. Thus, DMARD-naive and DMARD-failure patient groups may be combined in future PsA progression and treatment decision studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>www.clinicaltrialsregister.eu. EudraCT: 2017\u2013003900-28.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae450","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T14:46:00Z","timestamp":1723905960000},"page":"1760-1769","source":"Crossref","is-referenced-by-count":2,"title":["Multimodal imaging of structural damage and inflammation in psoriatic arthritis: a comparison of DMARD-naive and DMARD-failure patients"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9910-5825","authenticated-orcid":false,"given":"Na\u011fme \u00d6","family":"Renkli","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke J","family":"Kleinrensink","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]},{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Spierings","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Mastbergen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-7718","authenticated-orcid":false,"given":"Harald E","family":"Vonkeman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medisch Spectrum Twente , Enschede,","place":["The Netherlands"]},{"name":"Department of Psychology, Health and Technology, University of Twente , Enschede,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasti C","family":"Mooij","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medisch Spectrum Twente , Enschede,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia G","family":"Schipper","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Elisabeth- TweeSteden Hospital , Tilburg,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Herman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Antonius Hospital , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"ten Katen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Nap","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein E","family":"Hol","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim A","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-6350","authenticated-orcid":false,"given":"Myl\u00e8ne P","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-8555","authenticated-orcid":false,"given":"Wouter","family":"Foppen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht University , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the TOFA-PREDICT Author Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavish J","family":"Bhansing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra T A","family":"van Bijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radjesh J","family":"Bisoendial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoaneta C","family":"Comarniceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenny Geurts-van","family":"Bon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z Nazira","family":"Jahangier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim L T A","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno W R","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmerik F A","family":"Leijten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid M","family":"van Tubergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone A","family":"Vreugdenhil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siska","family":"Wijngaarden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"2025040212132681500_keae450-B1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"New Engl J Med"},{"key":"2025040212132681500_keae450-B2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13244-021-01035-0","article-title":"Role of diagnostic imaging in psoriatic arthritis: how, when, and why","volume":"12","author":"Crespo-Rodr\u00edguez","year":"2021","journal-title":"Insights Imaging"},{"key":"2025040212132681500_keae450-B3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/2040622315582354","article-title":"Psoriatic arthritis: latest treatments and their place in therapy","volume":"6","author":"Kang","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"2025040212132681500_keae450-B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2015.07.003","article-title":"Clinical features and diagnostic considerations in psoriatic arthritis","volume":"41","author":"Gladman","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 2","key":"2025040212132681500_keae450-B5","doi-asserted-by":"crossref","first-page":"ii61","DOI":"10.1136\/ard.2004.030809","article-title":"Psoriatic arthritis imaging: a review of scoring methods","volume":"64","author":"Van Der Heijde","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2025040212132681500_keae450-B6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11926-008-0049-y","article-title":"MRI in psoriatic arthritis: insights into pathogenesis and treatment response","volume":"10","author":"McQueen","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"2025040212132681500_keae450-B7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3899\/jrheum.181093","article-title":"The OMERACT MRI in enthesitis initiative: definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system","volume":"46","author":"Mathew","year":"2019","journal-title":"J Rheumatol"},{"key":"2025040212132681500_keae450-B8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3899\/jrheum.090352","article-title":"The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS): definitions of Key Pathologies, Suggested MRI Sequences, and Preliminary Scoring System for PsA Hands","volume":"36","author":"Ostergaard","year":"2009","journal-title":"J Rheumatol"},{"key":"2025040212132681500_keae450-B9","doi-asserted-by":"crossref","first-page":"909760","DOI":"10.3389\/fimmu.2022.909760","article-title":"PET\/CT-based characterization of 18F-FDG uptake in various tissues reveals novel potential contributions to coronary artery disease in psoriatic arthritis","volume":"13","author":"Schwartz","year":"2022","journal-title":"Front Immunol"},{"key":"2025040212132681500_keae450-B10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/rg.2020190047","article-title":"Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review","volume":"40","author":"Hotta","year":"2020","journal-title":"RadioGraphics"},{"key":"2025040212132681500_keae450-B11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025040212132681500_keae450-B12","first-page":"e3777","article-title":"Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT)","volume":"63","author":"Mehta","year":"2012","journal-title":"J Vis Exp"},{"key":"2025040212132681500_keae450-B13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025040212132681500_keae450-B14","doi-asserted-by":"crossref","first-page":"e064338","DOI":"10.1136\/bmjopen-2022-064338","article-title":"TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)","volume":"12","author":"Kleinrensink","year":"2022","journal-title":"BMJ Open"},{"issue":"Suppl 10","key":"2025040212132681500_keae450-B15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acr.24242","article-title":"Measuring outcomes in psoriatic arthritis","volume":"72","author":"Ogdie","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025040212132681500_keae450-B16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0035-1564696","article-title":"Recommendations of the ESSR arthritis subcommittee for the use of magnetic resonance imaging in musculoskeletal rheumatic diseases","volume":"19","author":"Sudo\u0142-Szopi\u0144ska","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"key":"2025040212132681500_keae450-B17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00259-015-3259-3","article-title":"Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis","volume":"43","author":"Bucerius","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025040212132681500_keae450-B18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiol.2015142088","article-title":"Imaging for staging and response assessment in lymphoma","volume":"276","author":"Johnson","year":"2015","journal-title":"Radiology"},{"key":"2025040212132681500_keae450-B19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003547","article-title":"Increased vascular inflammation on PET\/CT in psoriatic arthritis patients in comparison with controls","volume":"10","author":"Kleinrensink","year":"2024","journal-title":"RMD Open"},{"key":"2025040212132681500_keae450-B20","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In Vivo 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Provides a Noninvasive Measure of Carotid Plaque Inflammation in Patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025040212132681500_keae450-B21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41584-022-00810-7","article-title":"Sex- and gender-related differences in psoriatic arthritis","volume":"18","author":"Tarannum","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212132681500_keae450-B22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2012-201357","article-title":"Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025040212132681500_keae450-B23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/1744666X.2019.1543591","article-title":"The relationship between smoking, psoriasis and psoriatic arthritis","volume":"15","author":"Pezzolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2025040212132681500_keae450-B24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"British Journal of Dermatology"},{"key":"2025040212132681500_keae450-B25","first-page":"890","article-title":"Foundations of the minimal clinically important difference for imaging","volume":"28","author":"Lassere","year":"2001","journal-title":"J Rheumatol"},{"key":"2025040212132681500_keae450-B26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s12350-023-03204-8","article-title":"Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: a prospective cohort FDG PET study","volume":"30","author":"Boczar","year":"2023","journal-title":"J Nuclear Cardiol"},{"key":"2025040212132681500_keae450-B27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-022-02797-8","article-title":"Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial","volume":"24","author":"Baraliakos","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025040212132681500_keae450-B28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/annrheumdis-2013-204229","article-title":"High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission","volume":"74","author":"Araujo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025040212132681500_keae450-B29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/rheumatology\/key032","article-title":"Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial","volume":"57","author":"Wells","year":"2018","journal-title":"Rheumatology"},{"key":"2025040212132681500_keae450-B30","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology"},{"key":"2025040212132681500_keae450-B31","doi-asserted-by":"crossref","first-page":"e000638","DOI":"10.1136\/rmdopen-2017-000638","article-title":"Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry","volume":"4","author":"Mease","year":"2018","journal-title":"RMD Open"},{"key":"2025040212132681500_keae450-B32","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2011.150938","article-title":"Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?","volume":"70","author":"Gladman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025040212132681500_keae450-B33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-015-3365-3","article-title":"Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires","volume":"36","author":"Shin","year":"2016","journal-title":"Rheumatol Int"},{"key":"2025040212132681500_keae450-B34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00296-010-1673-1","article-title":"Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel","volume":"32","author":"Zisman","year":"2012","journal-title":"Rheumatol Int"},{"key":"2025040212132681500_keae450-B35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/kev443","article-title":"Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetry","volume":"55","author":"Szentpetery","year":"2016","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae450\/59274995\/keae450.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1760\/59274995\/keae450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1760\/59274995\/keae450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:31:47Z","timestamp":1743618707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1760\/7734923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,17]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae450","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,8,17]]}}}